Investigational Site 020 — Wilkes-Barre, Pennsylvania

Investigational Site 020 is a clinical research site located in Wilkes-Barre, Pennsylvania, United States 18711.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site 020 has participated in 1 clinical trials.

Therapeutic areas: Clostridium Difficile Infection.

Sponsors: Sanofi Pasteur, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 020?

Investigational Site 020 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 020 conducted?

Investigational Site 020 has 1 clinical trials on record. Their work covers Clostridium Difficile Infection.

Is Investigational Site 020 accredited by Crixeo Health?

Investigational Site 020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.